End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
36.2 TWD | +1.26% | +3.58% | +9.04% |
Business Summary
Number of employees: 87
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Self-produced Specific Pathogen Free Laboratory Mice and Laboratory Animals Related Services
52.7
%
| 136 | 57.5 % | 140 | 52.7 % | +2.97% |
Instruments, Equipment and Reagents
34.9
%
| 71 | 29.9 % | 92 | 34.9 % | +30.75% |
Other
12.4
%
| 30 | 12.6 % | 33 | 12.4 % | +10.32% |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Taiwan
98.0
%
| 231 | 98.0 % | 259 | 98.0 % | +12.13% |
Other
2.0
%
| 5 | 2.0 % | 5 | 2.0 % | +16.12% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chen Chung Chen
CEO | Chief Executive Officer | - | 09/01/09 |
Yue Ching Yu
DFI | Director of Finance/CFO | - | 01/14/01 |
Lei Yao Chang
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chen Chung Chen
CEO | Chief Executive Officer | - | 09/01/09 |
Li Chu Wu
BRD | Director/Board Member | - | 19/14/19 |
Chun Wei Chen
BRD | Director/Board Member | - | 22/17/22 |
Ming Chieh Chen
BRD | Director/Board Member | - | 19/18/19 |
Hsing Hua Su
BRD | Director/Board Member | - | 19/18/19 |
Han Tan Cheng
BRD | Director/Board Member | - | 19/18/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 25,612,000 | 13,910,400 ( 54.31 %) | 0 | 54.31 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+9.04% | 2.85Cr | |
+43.36% | 5.46TCr | |
-5.31% | 3.99TCr | |
+14.75% | 2.69TCr | |
-12.56% | 2.62TCr | |
-22.45% | 1.88TCr | |
+25.12% | 1.22TCr | |
+0.04% | 1.22TCr | |
+26.04% | 1.19TCr | |
-11.83% | 1.07TCr |
- Stock Market
- Equities
- 6662 Stock
- Company BioLASCO Taiwan Co., Ltd.